Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endothelial cell activation as a pathogenetic factor in preeclampsia.

Literature DB >> 2063233

Endothelial cell activation as a pathogenetic factor in preeclampsia.

J M Roberts¹, R N Taylor, A Goldfien.

Abstract

Mesh：

Substances：

Year: 1991 PMID： 2063233

Source DB: PubMed Journal: Semin Perinatol ISSN： 0146-0005 Impact factor: 3.300

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors: Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal: J Matern Fetal Neonatal Med Date: 2011-08-25

2. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Authors: Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero
Journal: J Matern Fetal Neonatal Med Date: 2008-01

3. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.

Authors: Tinnakorn Chaiworapongsa; Roberto Romero; Francesca Gotsch; Jimmy Espinoza; Jyh Kae Nien; Luis Goncalves; Samuel Edwin; Yeon Mee Kim; Offer Erez; Juan Pedro Kusanovic; Beth L Pineles; Zoltan Papp; Sonia Hassan
Journal: J Matern Fetal Neonatal Med Date: 2008-01

Endothelial cell activation as a pathogenetic factor in preeclampsia.

1. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

2. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

3. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.

4. ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

5. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia.

Review 6. An unexpected tail of VEGF and PlGF in pre-eclampsia.

Review 7. Hypertension in pregnancy: natural history and treatment options.

8. Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia.

9. The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.